FIRST-LINE TREATMENT PATTERNS AMONG PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER (LA/MUC): A SYSTEMATIC LITERATURE REVIEW

被引：0
|
作者：
Kearney, M. [1 ]
Zhang, L. [2 ]
Hubscher, E. [2 ]
Musat, M. [2 ]
Harricharan, S. [2 ]
Wilke, T. [3 ]
机构：
[1] Merck Healthcare KgaA, Darmstadt, HE, Germany
[2] Cytel, Waltham, MA USA
[3] Univ Wismar, Wismar, Germany
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR124
引用
收藏
页码：S414 / S414
页数：1
相关论文
共 50 条
  • [41] EBANO study: Clinical characteristics, treatment patterns and survival results in patients with locally advanced/ metastatic urothelial carcinoma (la/mUC) in northern Spain
    Fernandez-Rodriguez, R.
    Sagastibelza, N.
    Pujol Obis, E.
    Lainez Milagro, N.
    Sanchez-Escribano, R.
    Martinez Kareaga, M.
    Verdun Aguilar, J. A.
    Arruti Ibarbia, M.
    Pumares Gonzalez, M.
    De Portugal Fernandez del Rivero, T.
    Lacalle, A.
    Gil Arnaiz, I.
    Pereira-Elorrieta, A.
    Duran Martinez, I.
    ANNALS OF ONCOLOGY, 2023, 34 : S1213 - S1213
  • [42] The Rapidly Evolving Landscape of First-Line Targeted Therapy in Metastatic Urothelial Cancer: A Systematic Review
    Lavoie, Jean-Michel
    Sridhar, Srikala S.
    Ong, Michael
    North, Scott
    Alimohamed, Nimira
    McLeod, Deanna
    Eigl, Bernhard J.
    ONCOLOGIST, 2021, 26 (08): : E1381 - E1394
  • [43] Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer
    Riemsma, Rob
    Forbes, C. A.
    Kessels, A.
    Lykopoulos, K.
    Amonkar, M. M.
    Rea, D. W.
    Kleijnen, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 123 (01) : 9 - 24
  • [44] Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer
    Rob Riemsma
    C. A. Forbes
    A. Kessels
    K. Lykopoulos
    M. M. Amonkar
    D. W. Rea
    J. Kleijnen
    Breast Cancer Research and Treatment, 2010, 123 : 9 - 24
  • [45] COST-EFFECTIVENESS OF AVELUMAB AS FIRST-LINE MAINTENANCE TREATMENT FOR LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN FINLAND
    Karttunen, E.
    Jaaskelainen, S.
    Hervonen, P.
    Chang, J.
    Kearney, M.
    VALUE IN HEALTH, 2022, 25 (01) : S99 - S99
  • [46] First-line treatment patterns in HR+/HER2-locally advanced or metastatic breast cancer in Europe
    Lewis, K.
    Kurosky, S.
    Last, M.
    Mitra, D.
    Lambert, A.
    Mahtani, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S371 - S372
  • [47] First-Line Systemic Therapy Outcomes in Western Population with Locally Advanced and Metastatic Gastric Cancer-A Systematic Review
    Marupuru, Srujitha
    Arku, Daniel
    Axon, David R.
    Villa-Zapata, Lorenzo
    Yaghoubi, Mohsen
    Slack, Marion K.
    Warholak, Terri
    GASTROENTEROLOGY INSIGHTS, 2023, 14 (04) : 515 - 537
  • [48] Real-world prescribing patterns for first-line and maintenance treatment of patients with advanced urothelial cancer (UC)
    Inderjeeth, Andrisha-Jade
    O'haire, Sophie
    Gibbs, Peter
    Wong, Lih-Ming
    Zhang, Alison
    Manohar, Paul
    James, Lynam
    Sengupta, Shomik
    Wong, Shirley
    Weickhardt, Andrew
    Tran, Ben
    Conduit, Ciara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 95 - 95
  • [49] Real-World Treatment Patterns, Sequencing, and Outcomes in Patients with Locally Advanced or Metastatic Urothelial Carcinoma Receiving Avelumab First-Line Maintenance in the United States
    Moon, Helen H.
    Kearney, Mairead
    Mahmoudpour, Seyed Hamidreza
    Ike, Chiemeka
    Morris, Valerie
    Rava, Andrew
    Kim, Sonia
    Sun, Haiyan
    Boyd, Marley
    Gomez Rey, Gabriel
    CURRENT ONCOLOGY, 2024, 31 (09) : 5662 - 5676
  • [50] Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis
    Mohammad, N. Haj
    ter Veer, E.
    Ngai, L.
    Mali, R.
    van Oijen, M. G. H.
    van Laarhoven, H. W. M.
    CANCER AND METASTASIS REVIEWS, 2015, 34 (03) : 429 - 441
12345